Cardioneuroablation for the effective treatment of recurrent vasovagal syncope to restore driving abilities.
Agnieszka Reichert, Antoni Wileczek, Sebastian Stec
https://pubmed.ncbi.nlm.nih.gov/35946179/Actively Recruiting
Led by American Heart of Poland · Updated on 2024-03-18
300
Participants Needed
2
Research Sites
17 weeks
Total Duration
Researchers are evaluating two different approaches to treat functional Atrio-Ventricular Block AVB, a heart condition affecting electrical conduction. This trial compares the usual elective pacemaker PM implantation recommended by guidelines with a newer method involving cardiovascular autonomic tests CAT, electrophysiologic assessment EPS, and a procedure called cardioneuroablation CNA. The study aims to see if CNA can safely and effectively treat AVB without the need for a permanent pacemaker, validating current recommendations and exploring an alternative treatment option. The trial will include at least 100 participants aged 18 to 75 with AVB and a positive atropine test. Participants will be randomly assigned to receive either early pacemaker implantation Group A or undergo CATEPS followed by CNA with possible delayed pacemaker implantation if needed Group B. Those opting out of randomization enter a registry with personalized treatment choices. Group A will receive pacemakers with telemonitoring, while Group B will get implantable loop recorders and undergo CNA under general anesthesia. If CNA is unsuccessful, pacemaker implantation may follow. Participants will be involved for at least 12 months, undergoing regular check-ups at baseline, 3, 6, and 12 months. Assessments include ECG telemonitoring, quality of life and symptom questionnaires, and cardiovascular autonomic tests with telemedicine support. Safety will be closely monitored monthly, focusing on major cardiovascular events. The study uses telemonitoring devices and provides 247 contact with specialized medical staff. Data on symptoms, fatigue, depression, and sleep will also be collected to evaluate treatment effects comprehensively.
CONDITIONS
Pacemaker Implantation Versus Cardioneuroablation for Functional Atrioventricular Block
S
Sebastian M Stec, MD, PhD
E
Edyta Stodolkiewicz-Nowarska, MD PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
American Heart of Poland
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and randomization visit
Duration - Up to 12 months
Participants receive either elective pacemaker implantation or cardioneuroablation with implantable loop recorder monitoring, depending on their assigned group. Participants undergo cardiovascular autonomic testing, electrophysiological studies, and extracardiac vagal nerve stimulation as part of treatment and evaluation procedures. Those in the cardioneuroablation group may receive a second ablation or pacemaker implantation if needed.
Regular telemedicine contacts and periodic in-person follow-up visits during 12 months
Duration - 12 months after treatment start
Participants are monitored for safety and efficacy outcomes including major adverse cardiovascular events and quality of life assessments through telemedicine and in-person visits.
Visits at 0, 3, 6, and 12 months including assessments and questionnaires
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Agnieszka Reichert, Antoni Wileczek, Sebastian Stec
https://pubmed.ncbi.nlm.nih.gov/35946179/Tolga Aksu, Rakesh Gopinathannair, Serdar Bozyel...
https://pubmed.ncbi.nlm.nih.gov/34465122/Jose Carlos M Pachon, Enrique Indalecio M Pachon, Maria Zelia Cunha Pachon...
https://pubmed.ncbi.nlm.nih.gov/21712276/Robert Gajda, Beat Knechtle, Anita Gębska-Kuczerowska...
https://pubmed.ncbi.nlm.nih.gov/36012002/Michael Glikson, Jens Cosedis Nielsen, Mads Brix Kronborg...
https://pubmed.ncbi.nlm.nih.gov/34455430/Tolga Aksu, Tümer Erdem Güler, Serdar Bozyel...
https://pubmed.ncbi.nlm.nih.gov/28106018/Yan Yao, Rui Shi, Tom Wong...
https://pubmed.ncbi.nlm.nih.gov/22275485/Wei Sun, Lihui Zheng, Yu Qiao...
https://pubmed.ncbi.nlm.nih.gov/27402231/Tolga Aksu, Ebru Golcuk, Kivanç Yalin...
https://pubmed.ncbi.nlm.nih.gov/26411271/Monika Klank-Szafran, Sebastian Stec, Janusz Sledź...
https://pubmed.ncbi.nlm.nih.gov/20806214/American Heart of Poland
Lead Sponsor